Suppr超能文献

多区域胰管内乳头状黏液性肿瘤全外显子组测序揭示低级别区域频繁发生体细胞突变。

Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic mutations predominantly in low-grade regions.

机构信息

Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.

出版信息

Gut. 2021 May;70(5):928-939. doi: 10.1136/gutjnl-2020-321217. Epub 2020 Oct 7.

Abstract

OBJECTIVE

Intraductal papillary mucinous neoplasms (IPMNs) are non-invasive precursor lesions that can progress to invasive pancreatic cancer and are classified as low-grade or high-grade based on the morphology of the neoplastic epithelium. We aimed to compare genetic alterations in low-grade and high-grade regions of the same IPMN in order to identify molecular alterations underlying neoplastic progression.

DESIGN

We performed multiregion whole exome sequencing on tissue samples from 17 IPMNs with both low-grade and high-grade dysplasia (76 IPMN regions, including 49 from low-grade dysplasia and 27 from high-grade dysplasia). We reconstructed the phylogeny for each case, and we assessed mutations in a novel driver gene in an independent cohort of 63 IPMN cyst fluid samples.

RESULTS

Our multiregion whole exome sequencing identified , a previously unreported genetic driver of IPMN tumorigenesis, with hotspot mutations in one of two codons identified in >50% of the analyzed IPMNs. Mutations in were significantly more prevalent in low-grade regions in our sequenced cases. Phylogenetic analyses of whole exome sequencing data demonstrated diverse patterns of IPMN initiation and progression. Hotspot mutations in were also identified in an independent cohort of IPMN cyst fluid samples, again with a significantly higher prevalence in low-grade IPMNs.

CONCLUSION

Hotspot mutations in occur at high prevalence in IPMNs. Unique among pancreatic driver genes, mutations are enriched in low-grade IPMNs. These data highlight distinct molecular features of low-grade and high-grade dysplasia and suggest diverse pathways to high-grade dysplasia via the IPMN pathway.

摘要

目的

导管内乳头状黏液性肿瘤(IPMNs)是一种非浸润性的前体病变,可进展为浸润性胰腺癌,并根据肿瘤上皮的形态学特征分为低级别或高级别。我们旨在比较同一 IPMN 的低级别和高级别区域的遗传改变,以确定肿瘤进展的分子改变。

设计

我们对 17 例同时存在低级别和高级别异型增生的 IPMN 组织样本进行了多区域全外显子组测序(76 个 IPMN 区域,包括 49 个来自低级别异型增生和 27 个来自高级别异型增生)。我们为每个病例重建了系统发育树,并在 63 例 IPMN 囊液样本的独立队列中评估了一个新的驱动基因中的突变。

结果

我们的多区域全外显子组测序确定了,这是一种以前未报道的 IPMN 肿瘤发生的遗传驱动因素,在分析的 IPMNs 中超过 50%的两个密码子中都有热点突变。在我们测序的病例中,低级别区域的突变明显更为常见。全外显子组测序数据的系统发育分析表明了 IPMN 起始和进展的多种模式。在另一个独立的 IPMN 囊液样本队列中也发现了 中的热点突变,同样在低级别 IPMN 中更为常见。

结论

中的热点突变在 IPMNs 中发生率很高。在胰腺驱动基因中独一无二的是, 突变在低级别 IPMNs 中更为丰富。这些数据突出了低级别和高级别异型增生的不同分子特征,并表明通过 IPMN 途径向高级别异型增生存在不同的途径。

相似文献

2
Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
J Pathol. 2020 Nov;252(3):252-262. doi: 10.1002/path.5515. Epub 2020 Sep 19.
3
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.
Gastroenterology. 2019 Oct;157(4):1123-1137.e22. doi: 10.1053/j.gastro.2019.06.001. Epub 2019 Jun 5.
5
6
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
J Am Coll Surg. 2015 May;220(5):845-854.e1. doi: 10.1016/j.jamcollsurg.2014.11.029. Epub 2015 Feb 11.
9
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
Gastroenterology. 2019 Feb;156(3):647-661.e2. doi: 10.1053/j.gastro.2018.10.029. Epub 2018 Oct 17.
10
GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Virchows Arch. 2015 Jun;466(6):665-74. doi: 10.1007/s00428-015-1751-6. Epub 2015 Mar 22.

引用本文的文献

1
Applying multilevel selection to understand cancer evolution and progression.
PLoS Biol. 2025 Jul 18;23(7):e3003290. doi: 10.1371/journal.pbio.3003290. eCollection 2025 Jul.
3
Proteomics in pancreatic cancer.
Biomark Res. 2025 Jul 6;13(1):93. doi: 10.1186/s40364-025-00805-y.
4
Unraveling the therapeutic landscape of miRNAs in pancreatic cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 2. doi: 10.1007/s00210-025-04301-w.
6
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.
Cancers (Basel). 2024 Dec 6;16(23):4094. doi: 10.3390/cancers16234094.
7
Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts.
Front Immunol. 2024 Nov 7;15:1472433. doi: 10.3389/fimmu.2024.1472433. eCollection 2024.
9
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
Ther Adv Med Oncol. 2024 Jul 26;16:17588359241265213. doi: 10.1177/17588359241265213. eCollection 2024.

本文引用的文献

1
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines.
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):676-689. doi: 10.1038/s41575-019-0195-x. Epub 2019 Sep 16.
2
A multimodality test to guide the management of patients with a pancreatic cyst.
Sci Transl Med. 2019 Jul 17;11(501). doi: 10.1126/scitranslmed.aav4772.
3
CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers.
Cell Syst. 2019 Jul 24;9(1):9-23.e8. doi: 10.1016/j.cels.2019.05.005. Epub 2019 Jun 12.
4
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.
Gastroenterology. 2019 Oct;157(4):1123-1137.e22. doi: 10.1053/j.gastro.2019.06.001. Epub 2019 Jun 5.
5
and mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.
Gut. 2020 Apr;69(4):704-714. doi: 10.1136/gutjnl-2018-318059. Epub 2019 Jun 1.
6
Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions.
J Pathol. 2019 Mar;247(3):347-356. doi: 10.1002/path.5194. Epub 2019 Jan 16.
7
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
Gastroenterology. 2019 Feb;156(3):647-661.e2. doi: 10.1053/j.gastro.2018.10.029. Epub 2018 Oct 17.
8
IPMNs with co-occurring invasive cancers: neighbours but not always relatives.
Gut. 2018 Sep;67(9):1652-1662. doi: 10.1136/gutjnl-2017-315062. Epub 2018 Mar 2.
10
Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Science. 2018 Feb 23;359(6378):926-930. doi: 10.1126/science.aar3247. Epub 2018 Jan 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验